Share:
Peer-Reviewed Publication
J Alzheimers Dis2026;13872877261477084.August 28, 2026Journal Article

Multistrain probiotics modulate tau pathology and preserve visuospatial cognition in early cognitive impairment: A double-blind, randomized, placebo-controlled trial.

Eun Hyun Seo1,2, Sarang Kang3, Seung-Gon Kim4, Ja-Hae Kim5, Hye-Jung Yoon6, Kyu Yeong Choi1, Hyung-Jun Yoon4, Kun Ho Lee1,7,8, Kang-Ho Choi6
1Gwangju Alzheimer's Disease and Related Dementia Cohort Research Center, Chosun University, Gwangju, Republic of Korea.
2Premedical Science, College of Medicine, Chosun University, Gwangju, Republic of Korea.
3BK21-Four Educational Research Group for Age-Associated Disorder Control Technology, Chosun University, Gwangju, Republic of Korea.
4Department of Neuropsychiatry, Chosun University Hospital, Gwangju, Republic of Korea.
5Department of Nuclear Medicine, Chonnam National University Hospital and Medical School, Gwangju, Republic of Korea.
6Department of Neurology, Chonnam National University Hospital and Medical School, Gwangju, Republic of Korea.
7Department of Biomedical Science, Chosun University, Gwangju, Republic of Korea.
8Korea Brain Research Institute, Daegu, Republic of Korea.

Abstract

BackgroundThe gut-brain axis is increasingly implicated in Alzheimer's disease (AD) pathogenesis.ObjectiveTo investigate whether a multistrain probiotic supplement is associated with changes in AD-related plasma biomarkers and cognitive function in older adults with early cognitive impairment.MethodsIn this randomized, double-blind, placebo-controlled trial, eighty-seven participants from the Gwan…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.